better & safer glaucoma surgery product...

33
Better & Safer Glaucoma Surgery Product Introduction ICL-35-001(10) 1

Upload: others

Post on 20-Jun-2020

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Better & Safer Glaucoma Surgery Product Introductionioptima.co.il/.../uploads/2016/04/CLASS-Product-Introduction-Clinical.… · growing as age advances. Million. Patients Globally

Better & Safer Glaucoma Surgery

Product IntroductionICL-35-001(10)1

Page 2: Better & Safer Glaucoma Surgery Product Introductionioptima.co.il/.../uploads/2016/04/CLASS-Product-Introduction-Clinical.… · growing as age advances. Million. Patients Globally

About Glaucoma & the CLASS Solution

The IOPtiMate System & CLASS Technology

CLASS Procedure – Step by Step

CLASS Procedure – Clinical Results

Summary

Agenda

2 ICL-35-001(10)

Page 3: Better & Safer Glaucoma Surgery Product Introductionioptima.co.il/.../uploads/2016/04/CLASS-Product-Introduction-Clinical.… · growing as age advances. Million. Patients Globally

About Glaucoma & the CLASS Solution

3 ICL-35-001(10)

Page 4: Better & Safer Glaucoma Surgery Product Introductionioptima.co.il/.../uploads/2016/04/CLASS-Product-Introduction-Clinical.… · growing as age advances. Million. Patients Globally

Glaucoma is a group of eye diseases affecting the optic nerve and usually characterized by high intraocular pressure (IOP), which is the major risk factor for glaucoma.

Without treatment glaucoma can progress to loss of central vision and blindness.

Glaucoma What is it?

4 ICL-35-001(10)

Page 5: Better & Safer Glaucoma Surgery Product Introductionioptima.co.il/.../uploads/2016/04/CLASS-Product-Introduction-Clinical.… · growing as age advances. Million. Patients Globally

GlaucomaThe silent thief of sight

Glaucoma is the leading cause of irreversible blindness worldwide.

The elderly are most affected by glaucoma with incidence of the disease growing as age advances.

MillionPatients GloballyBy 202080Million

Patients GloballyTo Date70

5 ICL-35-001(10)

Page 6: Better & Safer Glaucoma Surgery Product Introductionioptima.co.il/.../uploads/2016/04/CLASS-Product-Introduction-Clinical.… · growing as age advances. Million. Patients Globally

Medications Office Procedures SurgeriesImprove aqueous outflow

and/or reduce the production of aqueous

Trabeculoplasty Trabeculectomy, Shunts, Tubes, Values, MIGS

GlaucomaTreatment protocol

IOPtima Target Market

• Limited compliance (only ~50%)

• Limited efficacy

• Limited decrease in IOP• Short term effect

(months)• Repeated procedures are

not effective

• Full penetration invasive (e.g. Trab) - high post-operation complications

• Minimally-invasive (e.g. MIGS) – limited effectiveness

6 ICL-35-001(10)

Page 7: Better & Safer Glaucoma Surgery Product Introductionioptima.co.il/.../uploads/2016/04/CLASS-Product-Introduction-Clinical.… · growing as age advances. Million. Patients Globally

TrabeculectomyBut at what cost?

There is an alternative• Similar IOP and medication reduction as

trabeculectomy at 5 years• More than 35% reduction in complications

compared to trabeculectomy

• Long-term reduction of IOP and medication use• High post-operative complication rate

7 ICL-35-001(10)

Page 8: Better & Safer Glaucoma Surgery Product Introductionioptima.co.il/.../uploads/2016/04/CLASS-Product-Introduction-Clinical.… · growing as age advances. Million. Patients Globally

The IOPtiMate System & CLASS Technology

8 ICL-35-001(10)

Page 9: Better & Safer Glaucoma Surgery Product Introductionioptima.co.il/.../uploads/2016/04/CLASS-Product-Introduction-Clinical.… · growing as age advances. Million. Patients Globally

The CLASS SolutionA New Surgical Approach

CLASS™ – CO2 Laser-Assisted Sclerectomy Surgery, utilizes IOPtiMate, a novel laser technology for performing Deep Sclerectomy glaucoma surgery.

“The system transforms complex and highly risky glaucoma surgery into a safe, elegant and precise laser-assisted procedure”Prof. Assia Ehud, Meir Medical Center, Kfar Saba. Israel

“IOPtima’s CLASS procedure has true advantages over the Trabeculectomy surgery as it offers an excellent safety profile with an ease of use”Prof. Mermoud Andre, Clinique de Montchoisi, Lausanne, Switzerland

9 ICL-35-001(10)

Page 10: Better & Safer Glaucoma Surgery Product Introductionioptima.co.il/.../uploads/2016/04/CLASS-Product-Introduction-Clinical.… · growing as age advances. Million. Patients Globally

The IOPtiMate system fits any ophthalmic microscope and consists of two main modules:

1. The Laser & Control Unit – Thesurgeon selects the programparameters on the LCD touch-screenand initiates the laser operation.

2. The Scanner – By using asophisticated system of Galvo-motorsand optics, the scanner takes thelaser beam and accurately ablates thesclera according to the preselectedshape & size scan pattern.

IOPtiMateTM System

10 ICL-35-001(10)

1

2

Page 11: Better & Safer Glaucoma Surgery Product Introductionioptima.co.il/.../uploads/2016/04/CLASS-Product-Introduction-Clinical.… · growing as age advances. Million. Patients Globally

IOPtiMateTM SystemThe CO2 laser

CO2 laser: well-known in the medical world for tissue ablation

11ICL-35-001(10)

Page 12: Better & Safer Glaucoma Surgery Product Introductionioptima.co.il/.../uploads/2016/04/CLASS-Product-Introduction-Clinical.… · growing as age advances. Million. Patients Globally

IOPtiMateTM SystemCO2 laser: tissue ablation

The laser spot isscanned very rapidly across the ablation pattern

Scanning is Faster than “thermal relaxation time” and by that limits the thermal damage

CO2 Laser: Principle of Operation

Ablation of Scleral Tissue

Effective ablation ofdry sclera by the CO2laser beam

Percolated fluidabsorbs laser energy and by that generates a self-limited safety mechanism

The laser beam isfocused to a small spot

Adequate fluidpercolation through intact thinned membrane (Schlemm’s Canal, TM)

12 ICL-35-001(10)

Page 13: Better & Safer Glaucoma Surgery Product Introductionioptima.co.il/.../uploads/2016/04/CLASS-Product-Introduction-Clinical.… · growing as age advances. Million. Patients Globally

CLASS Procedure – Step by Step

13 ICL-35-001(10)

Page 15: Better & Safer Glaucoma Surgery Product Introductionioptima.co.il/.../uploads/2016/04/CLASS-Product-Introduction-Clinical.… · growing as age advances. Million. Patients Globally

CLASSProcedure – step by step

Anesthesia & Eye fixation tilted down; Creation of conjunctiva flap (fornix base method)Creation of the standard flap (5.0 x 5.0 mm into clear cornea – expose the limbus; ⅓ to ½ thickness)

Creation of scleral lake and application of Mitomycin C

Place top of the scan pattern on the limbus line. Repeatedly perform controlled ablations of thin sclera layers until full exposure of the Schlemm’scanal

Fluid percolation through remaining trabeculum

A thin layer remains intact; penetration of the eye is avoided (histology)

The scleral flap is closed and suturedThe conjunctiva is closed and sutured

1

2

3

4

5

6

15ICL-35-001(10)

Page 17: Better & Safer Glaucoma Surgery Product Introductionioptima.co.il/.../uploads/2016/04/CLASS-Product-Introduction-Clinical.… · growing as age advances. Million. Patients Globally

Clear Zone

White Zone

Grey Zone

Limbus Line

CLASSPositioning the Ablation Pattern

ICL-35-001(10)

Page 18: Better & Safer Glaucoma Surgery Product Introductionioptima.co.il/.../uploads/2016/04/CLASS-Product-Introduction-Clinical.… · growing as age advances. Million. Patients Globally

CLASS Procedure – Clinical Results

18 ICL-35-001(10)

Page 19: Better & Safer Glaucoma Surgery Product Introductionioptima.co.il/.../uploads/2016/04/CLASS-Product-Introduction-Clinical.… · growing as age advances. Million. Patients Globally

CLASS Clinical Trial

19ICL-35-001(10)

Page 20: Better & Safer Glaucoma Surgery Product Introductionioptima.co.il/.../uploads/2016/04/CLASS-Product-Introduction-Clinical.… · growing as age advances. Million. Patients Globally

Clinical Results Safety (total n=108)

22 ICL-35-001(10)

Page 21: Better & Safer Glaucoma Surgery Product Introductionioptima.co.il/.../uploads/2016/04/CLASS-Product-Introduction-Clinical.… · growing as age advances. Million. Patients Globally

P<0.008 using Bonferroni correction for multiple comparisons

Clinical Results Efficacy –IOP & Med.

23ICL-35-001(10)

Page 22: Better & Safer Glaucoma Surgery Product Introductionioptima.co.il/.../uploads/2016/04/CLASS-Product-Introduction-Clinical.… · growing as age advances. Million. Patients Globally

Clinical Results Efficacy - %IOP reduction

24 ICL-35-001(10)

Page 23: Better & Safer Glaucoma Surgery Product Introductionioptima.co.il/.../uploads/2016/04/CLASS-Product-Introduction-Clinical.… · growing as age advances. Million. Patients Globally

Clinical Results Success Rate IOP≤18mmHg*

* Penetration by laser, additional glaucoma surgery and loss of 2 snellen lines in VA were considered as failure 25

ICL-35-001(10)

Page 24: Better & Safer Glaucoma Surgery Product Introductionioptima.co.il/.../uploads/2016/04/CLASS-Product-Introduction-Clinical.… · growing as age advances. Million. Patients Globally

Clinical Results CLASS vs. Trab – Avg. IOP

26 ICL-35-001(10)

Page 25: Better & Safer Glaucoma Surgery Product Introductionioptima.co.il/.../uploads/2016/04/CLASS-Product-Introduction-Clinical.… · growing as age advances. Million. Patients Globally

Clinical Results CLASS vs. Trab – no. of Med.

27 ICL-35-001(10)

Page 26: Better & Safer Glaucoma Surgery Product Introductionioptima.co.il/.../uploads/2016/04/CLASS-Product-Introduction-Clinical.… · growing as age advances. Million. Patients Globally

Clinical Results CLASS vs. Trab – Safety

28 ICL-35-001(10)

Page 27: Better & Safer Glaucoma Surgery Product Introductionioptima.co.il/.../uploads/2016/04/CLASS-Product-Introduction-Clinical.… · growing as age advances. Million. Patients Globally

Clinical Results CLASS vs. Trab – Safety (cont.)

29 ICL-35-001(10)

Page 28: Better & Safer Glaucoma Surgery Product Introductionioptima.co.il/.../uploads/2016/04/CLASS-Product-Introduction-Clinical.… · growing as age advances. Million. Patients Globally

Clinical Results Summary

Safety:

• Low Complication Rate

Efficacy:

• High and Consistent Success Rates

• Significant IOP reduction

• Controlled IOP over time

• Significant Medications reduction

30 ICL-35-001(10)

Page 29: Better & Safer Glaucoma Surgery Product Introductionioptima.co.il/.../uploads/2016/04/CLASS-Product-Introduction-Clinical.… · growing as age advances. Million. Patients Globally

Summary31 ICL-35-001(10)

Page 30: Better & Safer Glaucoma Surgery Product Introductionioptima.co.il/.../uploads/2016/04/CLASS-Product-Introduction-Clinical.… · growing as age advances. Million. Patients Globally

SummaryAdvantages of CLASS

Safe

Non-penetrating procedure

Self-regulated laser procedure

Doesn’t leave a foreign body in the eye

Less complications

Less post-op micro-manipulations

High comfort-level to the surgeon

Simple to perform

Short learning curve

Effective

long-term reduction of IOP – similar to Trab

Reduces the need for medications

More than 1500 patients have already been

operated worldwide

Simple to perform with short learning curve

Cost effective - Flexible business models

32ICL-35-001(10)

Typical Diffused Bleb at ~1 month follow-up

Page 31: Better & Safer Glaucoma Surgery Product Introductionioptima.co.il/.../uploads/2016/04/CLASS-Product-Introduction-Clinical.… · growing as age advances. Million. Patients Globally

KOLs endorse CLASS

33ICL-35-001(10)

Page 32: Better & Safer Glaucoma Surgery Product Introductionioptima.co.il/.../uploads/2016/04/CLASS-Product-Introduction-Clinical.… · growing as age advances. Million. Patients Globally

Thank you!34 ICL-35-001(10)

Page 33: Better & Safer Glaucoma Surgery Product Introductionioptima.co.il/.../uploads/2016/04/CLASS-Product-Introduction-Clinical.… · growing as age advances. Million. Patients Globally

Histology - Human Cadaver Eyes

Full thickness Cornea

Thin membrane leftAfter ablation

Flap

Ciliary body

AblatedArea

Human Cadaver Eye

35 ICL-35-001(10)